Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Immunopharmacology and Immunotoxicology
|
March 13, 2024
Immunosuppressants against acute kidney injury: what to prefer or to avoid?
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Purinergic Signalling
|
January 21, 2024
Molecular insights into P2X signalling cascades in acute kidney injury
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Fundamental & Clinical Pharmacology
|
August 5, 2024
Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, et al.
Food & Function
|
May 23, 2023
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury
Vishwadeep Shelke, Ajinath Kale, Neha Dagar, et al.
Organic & Biomolecular Chemistry
|
September 2, 2024
Shining light for organophotocatalysed site-selective sulfonylation of anilides
Swati Singh, Gopal Chakrabortty, Kajal Tiwari, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 4, 2023
ER stress modulated Klotho restoration: A prophylactic therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale, Vishwadeep Shelke, Tahib Habshi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 30, 2022
Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale, Vishwadeep Shelke, Himanshu Sankrityayan, et al.
Cell Biology International
|
February 27, 2025
Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress
Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar, et al.
Expert Opinion on Therapeutic Targets
|
November 11, 2024
ULK1 as a therapeutic target in kidney diseases: Current perspective
Shruti Shreya, Neha Dagar, Vishwadeep Shelke, et al.
Frontiers in Pharmacology
|
February 27, 2023
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Immunopharmacology and Immunotoxicology
|
March 13, 2024
Immunosuppressants against acute kidney injury: what to prefer or to avoid?
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Purinergic Signalling
|
January 21, 2024
Molecular insights into P2X signalling cascades in acute kidney injury
Swati Mishra, Vishwadeep Shelke, Neha Dagar, et al.
Fundamental & Clinical Pharmacology
|
August 5, 2024
Wnt/beta-catenin modulation: A promising frontier in chronic kidney disease management
Shubhangi Saxena, Neha Dagar, Vishwadeep Shelke, et al.
Food & Function
|
May 23, 2023
Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury
Vishwadeep Shelke, Ajinath Kale, Neha Dagar, et al.
Organic & Biomolecular Chemistry
|
September 2, 2024
Shining light for organophotocatalysed site-selective sulfonylation of anilides
Swati Singh, Gopal Chakrabortty, Kajal Tiwari, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
October 4, 2023
ER stress modulated Klotho restoration: A prophylactic therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale, Vishwadeep Shelke, Tahib Habshi, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 30, 2022
Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity
Ajinath Kale, Vishwadeep Shelke, Himanshu Sankrityayan, et al.
Cell Biology International
|
February 27, 2025
Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress
Tahib Habshi, Hrushikesh Kulkarni, Neha Dagar, et al.
Expert Opinion on Therapeutic Targets
|
November 11, 2024
ULK1 as a therapeutic target in kidney diseases: Current perspective
Shruti Shreya, Neha Dagar, Vishwadeep Shelke, et al.
Frontiers in Pharmacology
|
February 27, 2023
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Page
of 5